Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase II/III study of alpha-1 antitrypsin intravenous for treatment of actue graft-versus-host disease: Combined study for USA and Europe

Trial Profile

Phase II/III study of alpha-1 antitrypsin intravenous for treatment of actue graft-versus-host disease: Combined study for USA and Europe

Status: Recruiting
Phase of Trial: Phase II/III

Latest Information Update: 12 Feb 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Alpha 1-antitrypsin (Primary)
  • Indications Graft-versus-host disease
  • Focus Proof of concept; Therapeutic Use
  • Sponsors Kamada
  • Most Recent Events

    • 12 Feb 2019 According to a Kamada media release, enrollment is progressing well at five active sites and the company anticipates the completion of enrolment followed by the availability of interim data from this study by the end of 2019.
    • 12 Feb 2019 Status changed from planning to recruiting, according to a Kamada media release.
    • 04 Jan 2018 According to a Kamada media release, the study will be initiated in the first quarter of 2018. The Principal Investigator of the study is John Levine. Top-line results from this study are expected to be available in the second half of 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top